摘要 |
The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma. |
申请人 |
CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED;FISH, BRENDAN, CORMICK;LANGSTONE, JEANETTE, ELIZABETH;BANNISTER, KAREN;HOPE, CLAIRE, LOUISE |
发明人 |
FISH, BRENDAN, CORMICK;LANGSTONE, JEANETTE, ELIZABETH;BANNISTER, KAREN;HOPE, CLAIRE, LOUISE |